GEODE CAPITAL MANAGEMENT, LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTXTQ and the CUSIP is 71426V306. A total of 33 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2017. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2018$106,000
+135.6%
255,542
+442.3%
0.00%
Q3 2018$45,000
-60.5%
47,1260.0%0.00%
Q2 2018$114,000
+21.3%
47,126
+19.0%
0.00%
Q1 2018$94,000
-1.1%
39,595
-0.5%
0.00%
Q4 2017$95,000
-24.0%
39,8130.0%0.00%
Q3 2017$125,000
-21.9%
39,8130.0%0.00%
Q2 2017$160,000
+15.9%
39,813
+6.5%
0.00%
Q1 2017$138,000
+91.7%
37,395
+0.2%
0.00%
Q4 2016$72,00037,3230.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q2 2017
NameSharesValueWeighting ↓
Aisling Capital LLC 210,000$777,0000.14%
SEARLE & CO. 17,250$64,0000.04%
Jefferies Group LLC 259,200$959,0000.01%
Renaissance Technologies 740,650$2,740,0000.00%
Virtu KCG Holdings LLC 28,739$106,0000.00%
SIMPLEX TRADING, LLC 4,950$18,0000.00%
GROUP ONE TRADING, L.P. 19,945$74,0000.00%
NORTHERN TRUST CORP 11,976$45,0000.00%
Avior Wealth Management, LLC 70$00.00%
UBS Group AG 782$3,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders